Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

anti-infectives

This page shows the latest anti-infectives news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections

Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections

James Rusnak, senior vice president and chief development officer, internal medicine, anti-infectives and hospital, Pfizer, said: “We believe this data demonstrates that ATM-AVI, if approved, could be an important

Latest news

More from news
Approximately 4 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • Rebranding in an evolving world Rebranding in an evolving world

    This includes advancements in some of our key therapy areas that we believe will be of great value to patients, particularly in the anti-infectives space which has had limited investment

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    An immunologist with over two decades’ experience in anti-infectives research and drug development, Deborah set up Novabiotic Pharmaceuticals to discover and develop the next generation of treatments.

  • Deal Watch May 2016 Deal Watch May 2016

    Not only but also…. To close this month a recent report from the UK government expresses concerns about the lack of investment in anti-infectives R&D.

  • Another lost decade for research? Another lost decade for research?

    use but new classes of antibiotics - as well as non-antibiotic approaches such as other anti-infective treatments. ... Over the past 10 years the number of patent families filed in the antibiotics and anti-infectives field has remained stable, with

  • Pharma deals in June 2015 Pharma deals in June 2015

    CNS, diabetes, respiratory, vaccines and anti-infectives, oncology and autoimmune diseases. ... The consequences of acquisitions. One of the consequences of M&A is the need to assess a newly combined portfolio for potential anti-competitive issues.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Prior to that, McDevitt held positions with increasing responsibility within worldwide business development at GSK Ventures and Anti-Infectives Discovery.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Lavino joins the Austrian clinical-stage biopharma firm from Merck &Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. ... Prior to serving MSD as its acting vice president,

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management. ... Cidara focuses on the discovery, development and

  • Xellia forms scientific advisory board Xellia forms scientific advisory board

    Will further progress on innovative anti-infectives. Xellia Pharmaceuticals, who have a focus on anti-infective treatments, has announced the formation of a new scientific advisory board.

  • Melinta names chief medical officer Melinta names chief medical officer

    She has prior experience in developing anti-infectives, including Cubicin (daptomycin) during her time at Novartis, where she served as VP and global programme head for the company's immunology and ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....

Quick links